Early LDL-C target attainment after acute coronary syndrome: Superiority of upfront atorvastatin 40mg plus ezetimibe 10mg over high dose atorvastatin monotherapy in a Tunisian cohort
Archives of Cardiovascular Diseases · 2026-06 · 119 (6-7) · S186-S187
DOI: 10.1016/j.acvd.2026.03.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Cardiovascular Diseases, 2026-06. Verfasst von Haithem Touati und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Touati, H., Messaoudi, N., Salah, M., Dedde, B., Zemzem, S., Kchaou, A., Kerkani, F., & Denguir, H. (2026). Early LDL-C target attainment after acute coronary syndrome: Superiority of upfront atorvastatin 40mg plus ezetimibe 10mg over high dose atorvastatin monotherapy in a Tunisian cohort. Archives of Cardiovascular Diseases, 119(6-7), S186-S187. https://doi.org/10.1016/j.acvd.2026.03.007
Vancouver
Touati H, Messaoudi N, Salah M, Dedde B, Zemzem S, Kchaou A, et al. Early LDL-C target attainment after acute coronary syndrome: Superiority of upfront atorvastatin 40mg plus ezetimibe 10mg over high dose atorvastatin monotherapy in a Tunisian cohort. Archives of Cardiovascular Diseases. 2026;119(6-7):S186-S187. doi:10.1016/j.acvd.2026.03.007
BibTeX
@article{Touati2026,
author = {Touati, Haithem and Messaoudi, Noura and Salah, Marwa and Dedde, Bechir and Zemzem, Saddem and Kchaou, Amal and Kerkani, Fares and Denguir, Hichem},
title = {Early LDL-C target attainment after acute coronary syndrome: Superiority of upfront atorvastatin 40mg plus ezetimibe 10mg over high dose atorvastatin monotherapy in a Tunisian cohort},
journal = {Archives of Cardiovascular Diseases},
year = {2026},
volume = {119},
number = {6-7},
pages = {S186--S187},
doi = {10.1016/j.acvd.2026.03.007}
}
EUVIMED